Compile Data Set for Download or QSAR
Report error Found 21 Enz. Inhib. hit(s) with all data for entry = 1353
TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317598(US9624199, 8 | {6-[(2,6-Difluorobenzyl)(methyl)ami...)
Affinity DataIC50: 4.5nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317593(US9624199, 3 | {6-[(2R)-2-(Methoxymethyl)pyrrolidi...)
Affinity DataIC50: 11nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317603(US9624199, 13 | [6-(3-Methoxypyrrolidin-1-yl)pyrid...)
Affinity DataIC50: 12nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317597(US9624199, 7 | [3-(Cyclopropylmethoxy)-1,4′-...)
Affinity DataIC50: 13nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317607(US9624199, 17 | [3-(Cyclopropylmethoxy)-1,4′...)
Affinity DataIC50: 14nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317604(US9624199, 14 | {6-[(1-Methoxybutan-2-yl)amino]pyr...)
Affinity DataIC50: 16nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317595(US9624199, 5 | [6-(4,4-Difluoropiperidin-1-yl)pyri...)
Affinity DataIC50: 18nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317600(US9624199, 10 | (6-{[(2 S)-1-Hydroxybutan-2-yl]ami...)
Affinity DataIC50: 18nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317609(US9624199, 19 | [2-(4,4-Difluoropiperidin-1-yl)pyr...)
Affinity DataIC50: 19nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317602(US9624199, 12 | 2-[(5-{[(3R)-3-Methyl-1,4′-b...)
Affinity DataIC50: 21nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317608(US9624199, 18 | [(3R)-3-Methyl-1,4′-bipiperi...)
Affinity DataIC50: 24nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317599(US9624199, 9 | [6-(1,1-Dioxidothiomorpholin-4-yl)p...)
Affinity DataIC50: 27nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317605(US9624199, 15 | [(3R)-3-Methyl-1,4′-bipiperi...)
Affinity DataIC50: 27nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317591(US9624199, 1 | [(3R)-3-Methyl-1,4′-bipiperi...)
Affinity DataIC50: 28nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317596(US9624199, 6 | {6-[(2-Methoxyethyl)(methyl)amino]p...)
Affinity DataIC50: 33nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317594(US9624199, 4 | {6-[(2-Methoxyethyl)amino]pyridin-3...)
Affinity DataIC50: 36nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317610(US9624199, 20 | {2-[(2R)-2-(Methoxymethyl)pyrrolid...)
Affinity DataIC50: 41nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317592(US9624199, 2 | [(3R)-3-Methyl-1,4′-bipiperid...)
Affinity DataIC50: 50nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317606(US9624199, 16 | [(3R)-3-Methyl-1,4′-bipiperi...)
Affinity DataIC50: 54nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317601(US9624199, 11 | {6[(1-Hydroxybutan-2-yl)amino]pyri...)
Affinity DataIC50: 62nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetAlpha-1A adrenergic receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM317611(US9624199, 21 | [5-(1,1-Dioxidothiomorpholin-4-yl)...)
Affinity DataIC50: 71nMAssay Description:To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent